These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1506980)

  • 21. Myotonia in patients treated for cancer with didemnin B.
    Forman AD; Shin DM; Jackson R
    Muscle Nerve; 1992 Apr; 15(4):515-7. PubMed ID: 1314330
    [No Abstract]   [Full Text] [Related]  

  • 22. Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice.
    Weed SD; Stringfellow DA
    Antiviral Res; 1983 Nov; 3(4):269-74. PubMed ID: 6320719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Survey of Didemnin Depsipeptide Production in
    Stankey RJ; Johnson D; Duggan BM; Mead DA; La Clair JJ
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of Didemnin B in patients with advanced renal cell carcinoma.
    Motzer R; Scher H; Bajorin D; Sternberg C; Bosl GJ
    Invest New Drugs; 1990 Nov; 8(4):391-2. PubMed ID: 2084073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-protein conjugates: preparation of triamcinolone-acetonide containing bovine serum albumin/keyhole limpet hemocyanin-conjugates and polyclonal antibodies.
    Gabor F; Pittner F; Spiegl P
    Arch Pharm (Weinheim); 1995 Dec; 328(11-12):775-80. PubMed ID: 8585789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the organophosphorus nerve agent sarin by a competitive inhibition enzyme immunoassay.
    Zhou YX; Yan QJ; Ci YX; Guo ZQ; Rong KT; Chang WB; Zhao YF
    Arch Toxicol; 1995; 69(9):644-8. PubMed ID: 8660143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Didemnin B induces cell death by apoptosis: the fastest induction of apoptosis ever described.
    Grubb DR; Wolvetang EJ; Lawen A
    Biochem Biophys Res Commun; 1995 Oct; 215(3):1130-6. PubMed ID: 7488040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.
    Goss G; Muldal A; Lohmann R; Taylor M; Lopez P; Armitage G; Steward WP
    Invest New Drugs; 1995; 13(3):257-60. PubMed ID: 8729956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Didemnin B induces apoptosis in proliferating but not resting peripheral blood mononuclear cells.
    Baker MA; Grubb DR; Lawen A
    Apoptosis; 2002 Oct; 7(5):407-12. PubMed ID: 12207173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis.
    Crews CM; Lane WS; Schreiber SL
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4316-9. PubMed ID: 8633062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of Aplidin, a novel marine-derived antineoplastic agent, in human plasma.
    Yin J; Aviles P; Lee W; Ly C; Floriano P; Ignacio M; Faircloth G
    Rapid Commun Mass Spectrom; 2003; 17(16):1909-14. PubMed ID: 12876692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptide.
    Hossain MB; van der Helm D; Antel J; Sheldrick GM; Sanduja SK; Weinheimer AJ
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4118-22. PubMed ID: 3380783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiproliferative agent didemnin B uncompetitively inhibits palmitoyl protein thioesterase.
    Meng L; Sin N; Crews CM
    Biochemistry; 1998 Jul; 37(29):10488-92. PubMed ID: 9671519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the preparation of conjugates of leukotriene C4 with proteins for development of an immunoassay for SRS-A (1).
    Young RN; Kakushima M; Rokach J
    Prostaglandins; 1982 Apr; 23(4):603-13. PubMed ID: 7111766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo effect of didemnin B on two tumors of the rat.
    Fimiani V
    Oncology; 1987; 44(1):42-6. PubMed ID: 3561928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of serum amyloid P component by an enzyme-linked immunoassay.
    Serban D; Rordorf-Adam C
    J Immunol Methods; 1986 Jun; 90(2):159-64. PubMed ID: 3722822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of didemnin B, a depsipeptide from the sea.
    Li LH; Timmins LG; Wallace TL; Krueger WC; Prairie MD; Im WB
    Cancer Lett; 1984 Jul; 23(3):279-88. PubMed ID: 6744252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group study.
    Taylor SA; Goodman P; Crawford ED; Stuckey WJ; Stephens RL; Gaynor ER
    Invest New Drugs; 1992 Apr; 10(1):55-6. PubMed ID: 1607254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on the antibody against tetrodotoxin made by the immunogen with different carrier proteins].
    Liu Y; Zhong Q; Lei H; Zhang T; et al
    Wei Sheng Yan Jiu; 2008 Mar; 37(2):234-6. PubMed ID: 18589617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin inhibits didemnin B-induced apoptosis in human HL-60 cells: evidence for the possible involvement of FK506-binding protein 25.
    Johnson KL; Lawen A
    Immunol Cell Biol; 1999 Jun; 77(3):242-8. PubMed ID: 10361256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.